Axillary lymph node dissection.
Boullenois H, Peschaud F, Lupinacci RM.
J Visc Surg. 2023 Feb;160(1):55-59. doi: 10.1016/j.jviscsurg.2022.08.006. Epub 2022 Oct 1.
Axillary lymph node dissection: Dead or still alive?
Beck AC, Morrow M.
Breast. 2023 Jun;69:469-475. doi: 10.1016/j.breast.2023.01.009. Epub 2023 Jan 23.
Early experience of robotic axillary lymph node dissection in patients with node-positive breast cancer.
Ahn JH, Park JM, Choi SB, Go J, Lee J, Kim JY, Park HS.
Breast Cancer Res Treat. 2023 Apr;198(3):405-412. doi: 10.1007/s10549-022-06760-8. Epub 2022 Nov 23.
Contrast of Mastoscopic and Conventional Axillary Lymph Node Dissection of Patients With Breast Cancer: Meta-Analysis.
Xiong H, Chen Z, Xu L, Chen C, Fu Q, Teng R, Chen J, Xie S, Wang L, Yu XF, Zhou J.
Cancer Control. 2020 Apr-Jun;27(2):1073274820932987. doi: 10.1177/1073274820932987.
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.
Tinterri C, Canavese G, Gatzemeier W, Barbieri E, Bottini A, Sagona A, Caraceni G, Testori A, Di Maria Grimaldi S, Dani C, Boni L, Bruzzi P, Fernandes B, Scorsetti M, Zambelli A, Gentile D; SINODAR-ONE Collaborative Group.
Br J Surg. 2023 Aug 11;110(9):1143-1152. doi: 10.1093/bjs/znad215.
The problem of axillary staging in breast cancer after neoadjuvant chemotherapy. Role of targeted axillary dissection and types of lymph node markers.
Flores-Funes D, Aguilar-Jiménez J, Martínez-Gálvez M, Ibáñez-Ibáñez MJ, Carrasco-González L, Gil-Izquierdo JI, Aguayo-Albasini JL.
Cir Esp (Engl Ed). 2020 Nov;98(9):510-515. doi: 10.1016/j.ciresp.2020.03.012. Epub 2020 May 6.
To Perform an Axillary Lymph Node Dissection or Not? That Is (Still) the Question.
Fisher CS.
Ann Surg Oncol. 2020 Oct;27(10):3565-3566. doi: 10.1245/s10434-020-08692-3. Epub 2020 Jun 4.
Axillary lymph node dissection vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis.
Petousis S, Christidis P, Margioula-Siarkou C, Liberis A, Vavoulidis E, Margioula-Siarkou G, Vatopoulou A, Papanikolaou A, Mavromatidis G, Dinas K.
Arch Gynecol Obstet. 2022 Oct;306(4):1221-1234. doi: 10.1007/s00404-022-06458-8. Epub 2022 Mar 5.
Non-invasive predictors of axillary lymph node burden in breast cancer: a single-institution retrospective analysis.
Ngai V, Tai JCJ, Taj S, Khanfar H, Sfakianakis E, Bakalis A, Baker R, Ahmed M.
Breast Cancer Res Treat. 2022 Sep;195(2):161-169. doi: 10.1007/s10549-022-06672-7. Epub 2022 Jul 21.
Lymphedema After Axillary Lymph Node Dissection in Breast Cancer: Prevalence and Risk Factors-A Single-Center Retrospective Study.
Hara Y, Otsubo R, Shinohara S, Morita M, Kuba S, Matsumoto M, Yamanouchi K, Yano H, Eguchi S, Nagayasu T.
Lymphat Res Biol. 2022 Dec;20(6):600-606. doi: 10.1089/lrb.2021.0033. Epub 2022 Mar 29.
